Catalysts for Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd — Absorica (Phase II Trial Completion)

Sun Pharmaceutical Industries Ltd — ruxolitinib (Phase III Trial Initiation)

Methylphenidate Hydrochloride Tablet, Extended Release shortage — Sun Pharmaceutical Industries, Inc.

Technetium TC-99M Pyrophosphate Kit Injection shortage — Sun Pharmaceutical Industries, Inc.

Lisdexamfetamine Dimesylate Capsule shortage — Sun Pharmaceutical Industries, Inc.

Lisdexamfetamine Dimesylate Tablet, Chewable shortage — Sun Pharmaceutical Industries, Inc.

CALCITRIOL — FDA approval

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)

ISOTRETINOIN — FDA approval

ISOTRETINOIN — FDA approval

ABSORICA LD (ISOTRETINOIN) — FDA approval

ABSORICA (ISOTRETINOIN) — FDA approval

ISOTRETINOIN — FDA approval

ISOTRETINOIN — FDA approval

MYORISAN (ISOTRETINOIN) — FDA approval

ISOTRETINOIN — FDA approval

IBANDRONATE SODIUM — FDA approval

TRAMADOL HYDROCHLORIDE — FDA approval

SYNALGOS-DC (ASPIRIN) — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

METHADONE HYDROCHLORIDE — FDA approval

MEPERIDINE HYDROCHLORIDE — FDA approval

ILUMYA (TILDRAKIZUMAB-ASMN) — FDA approval

FARMAKEIO OUTSOURCING LLC recall (Cls II)

FARMAKEIO OUTSOURCING LLC recall (Cls II)

FARMAKEIO OUTSOURCING LLC recall (Cls II)

FARMAKEIO OUTSOURCING LLC recall (Cls II)

FARMAKEIO OUTSOURCING LLC recall (Cls II)

FARMAKEIO OUTSOURCING LLC recall (Cls II)